Connor, Clark & Lunn Investment Management (CC&L)
TARS icon

Connor, Clark & Lunn Investment Management (CC&L)’s Tarsus Pharmaceuticals TARS Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$2.45M Buy
2024
Q4 		– Sell
2024
Q3 		$1.55M Sell
2024
Q2 		$2.32M Sell
2024
Q1 		$3.53M Buy
2023
Q4 		$1.82M Buy
2023
Q3 		$723K Buy